UpTempo℠ AAV Platform Process
Summary: Catalent’s UpTempo℠ AAV Platform process is a scalable, CGMP-ready process for viral vector manufacturing that can reduce the current 18-20-month development timeline for drug product in half.
SIGN UP NOW TO STAY CURRENT WITH THE LATEST NEWS AND INSIGHTS
Main menu